Skip to main content

Peer Review reports

From: Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies

Original Submission
12 Dec 2021 Submitted Original manuscript
28 Dec 2021 Reviewed Reviewer Report
2 Jan 2022 Reviewed Reviewer Report
17 Jan 2022 Author responded Author comments - Bi-Cheng Wang
Resubmission - Version 2
17 Jan 2022 Submitted Manuscript version 2
4 Feb 2022 Reviewed Reviewer Report
20 Feb 2022 Reviewed Reviewer Report
2 Mar 2022 Author responded Author comments - Bi-Cheng Wang
Resubmission - Version 3
2 Mar 2022 Submitted Manuscript version 3
22 Mar 2022 Reviewed Reviewer Report
24 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Mar 2022 Editorially accepted
31 Mar 2022 Article published 10.1186/s12885-022-09469-5

You can find further information about peer review here.

Back to article page